[1] |
WANG Junda, LENG Jing, YANG yalin, LI Yanyan.
Analysis and treatment of adverse reactions associated with four gadolinium contrast agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1056-1062.
|
[2] |
LU Qing,ZENG Qingzhang, ZHOU Yaping, YU Peiming, LI Haona.
Analysis of adverse drug events of everolimus based on US FAERS database
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 547-551.
|
[3] |
YANG Rui, XU Haisha, ZHANG Zanling, QU Jian, LI Juan, PENG Shiqi, DAI Yuxin, QU Qiang.
Effect of drug interaction on anticoagulant strength of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1426-1431.
|
[4] |
MA Xiao-qin, XIN Hua-wen, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Wei-liang, WU Xiao-chun.
Association of HGPRT activity and gene polymorphism with adverse reactions caused by azathioprine in kidney transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 182-187.
|
[5] |
WANG Lin, QIU Xiao-yan.
Retrospective analysis of 119 cases with severe drug eruption
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 885-889.
|
[6] |
HU Hua, XIE Hai-tang, XU Zhe, PU Zhi-cheng, CHEN Qun, SUN Hua, ZHANG Xue-feng.
Development of ADRCAS ——adverse drug reactions comprehensive analysis system
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 712-716.
|
[7] |
YANG Xiao-jun, XIE Hai-tang, XU Wen-ke, JIAYuan-wei, ZHANG Wen.
Study on awareness of adverse drug reactions and Safe Drug Use knowledge among three kinds of medical stuff in a certain 3A-grade hospital
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 1008-1013.
|
[8] |
CHEN Bing, CAI Wei-min, YANG Wan-hua.
Genetic polymorphism of CYP2D6 and its influence on the personalized usage of antipsychotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1067-1074.
|
[9] |
CHEN Wang-qing, ZHANG Wei.
Mechanism of pharmacogenetics on drug withdrawal
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1065-1071.
|
[10] |
ZHOU Ping.
Study on the influence factors on the stability of cefuroxime, ceftriaxone and cefotaxime injections
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 770-774.
|
[11] |
ZHOU She-dian, LIANG Ping, ZHOU Gan-ping, CHEN Yu-qiang, LI Song.
Retrospective analysis of the 258 adxerse drug reaction cases in our hospital
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 690-693.
|
[12] |
HUANG Yu-Hong, ZHANG Bo-Li.
Causality assessment of signal adverse drug reaction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(6): 697-699.
|
[13] |
ZHANG Fan.
Adverse drug reaction reports in our hospital: survey of 202 cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(6): 718-720.
|
[14] |
LI Xian-tao, LIANG Wei-xiong, WANG Qi, WEN Ze-huai.
Values of interim analysis in drug clinical trials studies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 112-115.
|
[15] |
XIANG Nan, HU You-Zhi, SHI Jie, ZHANG Feng, FENG De-Xun.
Efficacy and safety of xindakang capsules in treatment of patients with angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 1033-1036.
|